The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index; 6 of the 65 sources its claims cite were checked for support.
Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase
Open accessAbstract
Two closely related glycosyltransferases are responsible for the final step of the biosynthesis of ABO(H) human blood group A and B antigens. The two enzymes differ by only four amino acid residues, which determine whether the enzymes transfer GalNAc from UDP-GalNAc or Gal from UDP-Gal to the H-antigen acceptor. The enzymes belong to the class of GT-A folded enzymes, grouped as GT6 in the CAZy database, and are characterized by a single domain with a metal dependent retaining reaction mechanism. However, the exact role of the four amino acid residues in the specificity of the enzymes is still unresolved. In this study, we report the first structural information of a dual specificity cis-AB blood group glycosyltransferase in complex with a synthetic UDP-GalNAc derivative. Interestingly, the GalNAc moiety adopts an unusual yet catalytically productive conformation in the binding pocket, which is different from the "tucked under" conformation previously observed for the UDP-Gal donor. In addition, we show that this UDP-GalNAc derivative in complex with the H-antigen acceptor provokes the same unusual binding pocket closure as seen for the corresponding UDP-Gal derivative. Despite this, the two derivatives show vastly different kinetic properties. Our results provide a important structural insight into the donor substrate specificity and utilization in blood group biosynthesis, which can very likely be exploited for the development of new glycosyltransferase inhibitors and probes.
Overview
CoChat Summary
TL;DR
The study reports the first crystal structures of the dual-specificity cis-AB blood group glycosyltransferase AAGlyB bound to a synthetic UDP-GalNAc derivative, revealing a non-canonical, catalytically productive GalNAc conformation. Combined with kinetics, the structures suggest that residues Gly266 and Ala268 enable AAGlyB to use both UDP-Gal and UDP-GalNAc and help explain donor specificity in blood group GTs.
Key findings
- The AAGlyB–3 structure shows the GalNAc moiety in an unusual conformation distinct from the canonical “tucked under” conformation seen with UDP-Gal, 1, or 2; O4′ hydrogen-bonds to Glu303 and His233, while O3′ hydrogen-bonds to the backbone of Gly267 and Ala268, with waters bridging to His301, Ser185, and Asp211.
- In the AAGlyB–3–HAA complex, binding of 3 and HAA triggers the same alternative C-terminal closed conformation previously seen in AAGlyB–1–HAA, with the HAA–His348 hydrogen bond disrupted; the sugar moiety is not seen in either complex.
- Compound 3 has a Km similar to that of 1 but is turned over about 25-fold faster; overall 3 resembles its parent UDP-GalNAc, with a Km about 3-fold lower and similar kcat and acceptor Km. AAGlyB hydrolyzes UDP-GalNAc at a rate ∼30 times higher than UDP-Gal, and 3 competes with UDP-Gal binding with a Ki in the same range as its Km.
- The specificity model proposes that Ala268 and Gly266 permit the alternative productive GalNAc conformation in AAGlyB, whereas GTB residues Met266 and Ala268 clash with both GalNAc conformations; GTA residues Leu266 and Gly268 could accommodate GalNAc in the tucked under conformation. Forssman synthetase has equivalent residues Gly and Ala as in AAGlyB.
Methods
- Compound 3 was synthesized by Suzuki–Miyaura cross-coupling of 5-iodo-UDP-GalNAc 4 with 5-formyl-2-thiopheneboronic acid, giving the target in 76% yield.
- Enzyme kinetics used capillary electrophoresis with a TMR-labeled HAA acceptor for Km and kcat of 3, a radiochemical SepPak assay for Ki, a Dowex hydrolysis assay, and 1H NMR to follow hydrolysis stereochemistry.
- Crystallography: AAGlyB–3 and AAGlyB–3–HAA structures were solved by molecular replacement using wild-type GTB (PDB 2RIT); both belong to space group P21212 with two molecules per asymmetric unit, refining to 1.75 Å and 1.65 Å with final Rfree values of 18.43% and 19.4%, respectively.
Limitations
- The paper states it cannot rule out a tucked under conformation of the GalNAc in wild-type GTA; the AAGlyB–3 structure provides information on residues 266 and 268 rather than directly resolving wild-type GTA donor binding.
- In AAGlyB–3, the GalNAc moiety has ∼60% occupancy, electron density suggests possible glycosidic bond cleavage, and the quality of the density did not justify modeling a glycal intermediate; chain A also showed hints of two GalNAc conformations that could not be modeled.
- The Ki assay does not differentiate between inhibitor and substrate behavior of 3 because the GalNAc moiety is not radiolabeled, and in the AAGlyB–3–HAA complex the sugar moiety is not seen, limiting direct comparison of donor sugar recognition in that ternary structure.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
3 Valid · 1 Not valid · 23 Not checked · 84 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“In this new structure, the GalNAc moiety is placed in the active site in a conformation, which is different from the canonical tucked under conformation previously observed in other UDP-sugar-GT complex structures (7, 12, 15–18, 20–24).”
- Also stated in: § Abstract · plain
“Interestingly, the GalNAc moiety adopts an unusual yet catalytically productive conformation in the binding pocket, which is different from the “tucked under” conformation previously observed for the UDP-Gal donor.”
§ Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase* > Introduction
What the sources say
- Partly supportedcites [7] Pesnot, 2010, Structural and mechanistic basis for a new mode of glycosyltransferase inhibition, Nat. Chem. Biol sourceExperimental — accuracy not yet measured
Our copy does report a sugar-nucleotide–GT complex in which the donor's sugar moiety sits in the donor-binding site in the canonical/classic orientation: the Results passage on the 1.45 Å AA(Gly)B–compound 2 structure states that 'Compound 2 adopts a classic "folded back" conformation and binds to the donor-binding site in the same orientation as previously described for 1 [15], with the Gal moiety interacting with Arg188, Asp211 and Asp302.' That supports the cited clause in general terms, but with two gaps: the ligand in this structure is a base-modified UDP-Gal analogue (Gal moiety, compound 2), not a native UDP-sugar and not a GalNAc donor, and nowhere in our copy is the 'tucked under' conformation described or named (searches for 'tucked under', canonical conformation, GalNAc moiety returned only the folded-back/semi-closed passages). Moreover the paper's own structural emphasis (Discussion/Results passages on Figure 1d–1e) is that the internal loop remains only 'semi-closed' with residues 178–185 disordered and the C-terminus unable to fold over the site, rather than a canonical closed complex. So part of what the sentence attributes to this reference — a previously observed canonical 'tucked under' UDP-sugar–GT complex — is not stated in it. (LLM, conf=0.70)
- Disputedcites [12] Jørgensen, 2013, Base-modified donor analogues reveal novel dynamic features of a glycosyltransferase, J. Biol. Chem sourceExperimental — accuracy not yet measured
Our copy's new structures involve base-modified UDP-Gal derivatives (1 and 2), i.e. a galactose donor, not a GalNAc moiety (the only GalNAc content is UDP-GalNAc kinetics in Table 2 and compound 3, a GalNAc congener whose structure 'will be published elsewhere'). Crucially, the RESULTS state that the novelty of the new ternary AAGlyB-1-HAA structure is an alternative closed conformation of the C terminus/internal loop, with no density for the sugar ('the galactose is either highly flexible or has been cleaved off'), and that where the sugar is resolved (AAGlyB-1, AAGlyB-2) it is in the canonical catalytically competent 'tucked under' conformation previously described for AABB-UDP-Gal-DA. This is contrary to the claim that in the new structure the sugar moiety sits in the active site in a conformation different from the tucked-under one. (LLM, conf=0.72)
Checked by a reasoning model — may be wrong.
- Supportedcites [15] Alfaro, 2008, ABO(H) blood group A and B glycosyltransferases recognize substrate via specific conformational changes, J. Biol. Chem source
The citation cluster is attached to the clause 'canonical tucked under conformation previously observed in other UDP-sugar-GT complex structures', i.e. Alfaro et al. 2008 is offered as one of the prior UDP-sugar–glycosyltransferase complex structures, not as the source of the citing paper's own new GalNAc-bound conformation. Our copy supports that: the 'UDP Binding Induces a Semi-closed Conformation' section states that in AABB+UDP-Gal+DA the donor sugar is bound in the classic 'folded back' conformation observed for other glycosyltransferases, and explicitly names it a 'tucked-under' conformation, comparing it with UDP-2-fluoro-Gal in α-(1→3)-GalT (refs 17,18). Note that our copy contains no UDP-GalNAc complex structure — Fig. 3f only models UDP-GalNAc in AABB to show it could not bind — so the 'different conformation' statement belongs to the citing work itself and is not attributed to this source. (LLM, conf=0.80)
- Not checked — no full text of the sourcecites [16] Persson, 2001, Crystal structure of the retaining galactosyltransferase LgtC from Neisseria meningitidis in complex with donor and acceptor sugar analogs, Nat. Struct. Biol source
- Not checked yetcites [17] Pruitt, 2012, Structural determinants of Clostridium difficile toxin A glucosyltransferase activity, J. Biol. Chem source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked — no full text of the sourcecites [18] Ramakrishnan, 2002, Crystal structure of β1,4-galactosyltransferase complex with UDP-Gal reveals an oligosaccharide acceptor binding site, J. Mol. Biol source
- Not checked yetcites [20] Negishi, 2003, Glucosaminylglycan biosynthesis: what we can learn from the x-ray crystal structures of glycosyltransferases GlcAT1 and EXTL2, Biochem. Biophys. Res. Commun source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [21] Pham, 2014, Structures of complexes of a metal-independent glycosyltransferase GT6 from Bacteroides ovatus with UDP-N-acetylgalactosamine (UDP-GalNAc) and its hydrolysis products, J. Biol. Chem source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [22] Reinert, 2005, Structural basis for the function of Clostridium difficile toxin B, J. Mol. Biol source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [23] Unligil, 2000, X-ray crystal structure of rabbit N-acetylglucosaminyltransferase I: catalytic mechanism and a new protein superfamily, EMBO J source
Checked before — its earlier verdict is held back until a new check runs.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Interestingly, the AAGlyB-3 structure shows the GalNAc ring in a conformation clearly different from the canonical tucked under conformation we have seen in previous blood group enzyme structures with UDP-Gal, 1, or 2 and which is the conformation generally adopted by both UDP-Gal and UDP-GalNAc at a GT binding site (Fig. 3) (7, 12, 15–18, 20, 22–24).”
- Also stated in: § Discussion · plain
“Intriguingly, this structure adopts a conformation different from the canonical tucked under conformation.”
§ Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase* > Results
What the sources say
- Not checked yetcites [7] Pesnot, 2010, Structural and mechanistic basis for a new mode of glycosyltransferase inhibition, Nat. Chem. Biol source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [12] Jørgensen, 2013, Base-modified donor analogues reveal novel dynamic features of a glycosyltransferase, J. Biol. Chem source
Checked before — its earlier verdict is held back until a new check runs.
- Partly supportedcites [15] Alfaro, 2008, ABO(H) blood group A and B glycosyltransferases recognize substrate via specific conformational changes, J. Biol. Chem sourceExperimental — accuracy not yet measured
Our copy of Alfaro et al. (2008) clearly supports the UDP-Gal half of the attributed background point: in the section 'UDP Binding Induces a Semi-closed Conformation' it states that in AABB+UDP-Gal+DA 'the donor sugar is bound in the classic "folded back" conformation observed for other glycosyltransferases (Fig. 3d)', that UDP-2-fluoro-Gal in bovine alpha-(1,3)-GalT 'lies in a "tucked-under" conformation (Fig. 3d)' like UDP-Gal in AABB, and Fig. 3 legend describes a superimposition of UDP-Gal in the active sites of AABB, GT7 and GT43. What our copy does not support is the extension to UDP-GalNAc: no UDP-GalNAc-bound structure is reported (intact bound donor was observed only for AABB with UDP-Gal), and UDP-GalNAc appears only as a model in the AABB site (Fig. 3f) used to show it could not bind there because of steric clash with Met 266/Ala 268. The conformational difference of the GalNAc ring in the citing paper's own AAGlyB-3 structure is not a point of this source. (LLM, conf=0.72)
- Not checked yetcites [16] Persson, 2001, Crystal structure of the retaining galactosyltransferase LgtC from Neisseria meningitidis in complex with donor and acceptor sugar analogs, Nat. Struct. Biol source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [17] Pruitt, 2012, Structural determinants of Clostridium difficile toxin A glucosyltransferase activity, J. Biol. Chem source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [18] Ramakrishnan, 2002, Crystal structure of β1,4-galactosyltransferase complex with UDP-Gal reveals an oligosaccharide acceptor binding site, J. Mol. Biol source
Checked before — its earlier verdict is held back until a new check runs.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“Binding of 3 and HAA triggers the C terminus of chain A to fold over the active site in the same alternative conformation (Fig. 2D) as previously seen in the AAGlyB-1-HAA structure (12), in which the donor analogue also has the 5-formylthienyl substituent.”
§ Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase* > Results
What the sources say
- Supportedcites [12] Jørgensen, 2013, Base-modified donor analogues reveal novel dynamic features of a glycosyltransferase, J. Biol. Chem source
The RESULTS section of our copy states that in the AAGlyB-1-HAA complex 'the C terminus of chain A has adopted an ordered state up until residue 353 (Figs. 5B and 7, A–C), which is folded over the donor binding site in a conformation alternative to that observed with the natural substrate', and the DISCUSSION calls this a new 'pseudo-closed' conformation seen for the first time. The same passage establishes that the donor analogue 1 carries the 5-formylthienyl substituent ('Trp-181 ... stacking ... to the formythienyl substituent of 1'). Figure 7 legend further compares the C terminus in the AAGlyB-1-HAA complex with a structure soaked with the GalNAc congener 3, noting both give the same 5-formylthienyl UDP hydrolysis product and 'the C terminus adopts the same orientation in both structures'. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Additionally, this GalNAc conformation in AAGlyB is also different from the GalNAc conformation recently described in the similar, but metal-independent GT (CAZy group GT6) from Bacteroides ovatus (21).”
§ Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase* > Results
What the sources say
- Supportedcites [21] Pham, 2014, Structures of complexes of a metal-independent glycosyltransferase GT6 from Bacteroides ovatus with UDP-N-acetylgalactosamine (UDP-GalNAc) and its hydrolysis products, J. Biol. Chem source
The cited work is exactly what the citing sentence identifies it as: the Abstract states 'Bacterial homologues of human blood group synthases (glycosyltransferase family GT6) differ in being metal-independent... The structure has been determined of a GT6 from Bacteroides ovatus in a complex with the substrate UDP-GalNAc', and the Results (section 'RESULTS AND DISCUSSION') describe the GalNAc conformations/orientations in the three ligand configurations (structure A intact UDP-GalNAc; structure B 'the GalNAc is displaced and reoriented relative to that in UDP-GalNAc'; structure C 'the GalNAc remains in a similar orientation and location to that in UDP-GalNAc'), including 'In structure C, the β-GalNAc C1 is in close contact with Gln192 NE2'. The difference relative to AAGlyB is the citing authors' own comparison, not a point attributed here; the metal-independence, CAZy GT6 assignment and B. ovatus origin are all stated in our copy ('No metal ions were identified in any of the structures'). Note only that our copy describes several GalNAc orientations rather than one ring-pucker conformation, so the singular 'the GalNAc conformation' is a mild simplification. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As previously seen for 1, compound 3 competes for binding with a Ki value, which is in the same range as Km for 3.”
§ Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase* > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
60 more claims
Create a free account to see all 111 claims and to verify the 57 references still open.
- It may state two separate claims as one. 34
- Probably not a substantial claim. 19
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase* > Discussion
“In GTB, residues 266 and 268 are an alanine and methionine, respectively”
§ Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase* > Introduction
“GTB has residues Gly176, Ser235, Met266, and Ala268 at the corresponding positions”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase* > Experimental Procedures > Data Collection, Reduction, and Structure Solution
“X-ray diffraction data were collected to 1.9-Å resolution on the AAGlyB-3 complex”
§ Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase* > Results
“The data diffracted to a maximum resolution of 1.75 and 1.65 Å with final Rfree values of 18.43 and 19.4% for AAGlyB-3 and AAGlyB-3-HAA, respectively.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase* > Results
“O3′ forms hydrogen bonds to the backbone of Gly267 and Ala268”
§ Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase* > Results
“| O3 | Gly267 O | Gly267 O | Ala268 N | 3.1/3.1/3.2 | O4 | Glu303 Oδ2 | 2.5 |”
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Kabsch, W. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889893005588 · Cited by 3,578
Glycosyltransferases: Structures, Functions, and Mechanisms
Lairson, L. L., Henrissat, B., Davies, G. J., & Withers, S. G. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.061005.092322 · Cited by 2,079
Likelihood-enhanced fast translation functions
McCoy, A. J., Grosse-Kunstleve, R. W., Storoni, L. C., & Read, R. J. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905001617 · Cited by 1,639
Molecular genetic basis of the histo-blood group ABO system
Yamamoto, F.-I., Clausen, H., White, T., Marken, J., & Hakomori, S.-I. (1990) · Nature · doi:10.1038/345229a0 · Cited by 1,181 · cited 1×
“[1] Radiochemical assay, with 100 M acceptor; [2] HPLC assay; [3] radiochemical assay, with 100 M donor; [4] donor: UDP-Gal (2 M); [5] donor: UDP-GalNAc (2 M).”
Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome
Rillahan, C. D., Antonopoulos, A., Lefort, C. T., Sonon, R., Azadi, P., Ley, K., Dell, A., Haslam, S. M., & Paulson, J. C. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.999 · Cited by 447
Cited by
Emerging structural insights into glycosyltransferase-mediated synthesis of glycans
Moremen, K. W., & Haltiwanger, R. S. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0350-2 · Cited by 209
Sobhanifar, S., Worrall, L. J., King, D. T., Wasney, G. A., Baumann, L., Gale, R. T., Nosella, M. L., Brown, E. D., Withers, S. G., & Strynadka, N. C. J. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006067 · Cited by 72
Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors
Li, S., McCraw, A. J., Gardner, R. A., Spencer, D. I. R., Karagiannis, S. N., & Wagner, G. K. (2021) · Antibodies · doi:10.3390/antib10040044 · Cited by 30
Self-citationMissing the sweet spot: one of the two N-glycans on human Gb3/CD77 synthase is expendable
Mikolajczyk, K. P., Bereźnicka, A., Szymczak-Kulus, K., Haczkiewicz-Leśniak, K., Szulc, B., Olczak, M., Rossowska, J., Majorczyk, E., Kapczyńska, K., Bovin, N. V., et al. (2021) · Glycobiology · doi:10.1093/glycob/cwab041 · Cited by 14
Kaczmarek, R., Mikołajewicz, K., Szymczak-Kulus, K., Duk, M., Majorczyk, E., Krop‐Watorek, A., Buczkowska, A., & Czerwiński, M. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9716-9 · Cited by 13
Metadata
- Authors
- Wagner, G. K., Pesnot, T., Palcic, M. M., & Jørgensen, R.
- Affiliations
- King's College London (GB)
- University of East Anglia (GB)
- Carlsberg Laboratory (DK)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 290
- Issue
- 52
- Pages
- 31162-31172
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC4692239
- OpenAlex
- W2147769824
- Cited by
- 12
- References
- 45
- Citations by year
- 2023: 2 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2016: 3 · 2015: 1
- FWCI
- 0.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 1753 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- HZB Repository (Helmholtz-Zentrum Berlin für Materialien und Energie GmbH (HZB)) (submittedVersion, other-oa)
- Funders
- Danmarks Frie Forskningsfond
- Medical Research Council (G0901746)
- Engineering and Physical Sciences Research Council (EP/D059186/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- UDP-GalNAc, ABO blood group antigens, H antigen, glycosyltransferase inhibitors, enzyme kinetics
- MeSH terms
- ABO Blood-Group System, Humans, Uridine Diphosphate Sugars, Glycosyltransferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.